Sign in to view content

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

Chirag D. Jhaveri, MD, FASRS

Video
Published 2022

Related

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Updates from the Field
2021
Wet AMD 5 Symposium
Annual Meeting Talks
2020
Outcomes of DRCR Network Treatment Regimen Starting With Observation for Eyes With Center-involved DME and Good Visual Acuity
Omar S. Punjabi, MD
Annual Meeting Talks
2019

Category: Diabetic Macular Edema

See more